Midgard Science

Labs / Assays & in vitro testing

Brenig Therapeutics

Dover, DE, United States · brenigther.com

Brenig Therapeutics is a biotechnology company developing small-molecule therapies for neurodegenerative diseases, starting with Parkinson’s disease. It is based in Somerville, Massachusetts, and works on clinical-stage programs and AI-enabled drug discovery for CNS disorders.

They take quote requests by email.

What they offer

  • AI-driven drug discovery platform

    Uses a hybrid platform that combines physics-based structural biology with machine learning to design and optimize small molecules.

  • Small-molecule therapeutic development

    Develops brain-penetrant small-molecule medicines for neurodegenerative and neuroinflammatory diseases.

  • Clinical-stage program development

    Advances internally developed programs from discovery into clinical development.

What they work on

Modalities
Small molecule, Antibody, Oligonucleotide
Therapeutic areas
Parkinson’s disease, neurodegenerative diseases, neuroinflammatory diseases, cardiometabolic diseases
Sites
Somerville, United States
Founded
2021

Similar labs. Aurigene Pharmaceutical Services, HitGen, Allumiqs, AxisPharm

Found in a contract services directory. Listing built from brenigther.com. Work here? Claim this listing.

Brenig Therapeutics · Midgard Science